Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 2
2015 23
2016 46
2017 42
2018 52
2019 59
2020 59
2021 95
2022 62
2023 61
2024 20

Text availability

Article attribute

Article type

Publication date

Cited In for PMID: 25234143

463 results

Results by year

Filters applied: . Clear all
Page 1
Targeting Siglec-Sialylated MUC1 Immune Axis in Cancer.
Ayyalasomayajula R, Cudic M. Ayyalasomayajula R, et al. Cancers (Basel). 2024 Mar 29;16(7):1334. doi: 10.3390/cancers16071334. Cancers (Basel). 2024. PMID: 38611013 Free PMC article. Review.
Sialic acids in infection and their potential use in detection and protection against pathogens.
Dedola S, Ahmadipour S, de Andrade P, Baker AN, Boshra AN, Chessa S, Gibson MI, Hernando PJ, Ivanova IM, Lloyd JE, Marín MJ, Munro-Clark AJ, Pergolizzi G, Richards SJ, Ttofi I, Wagstaff BA, Field RA. Dedola S, et al. RSC Chem Biol. 2023 Dec 19;5(3):167-188. doi: 10.1039/d3cb00155e. eCollection 2024 Mar 6. RSC Chem Biol. 2023. PMID: 38456038 Free PMC article. Review.
The receptor binding domain of SARS-CoV-2 Omicron subvariants targets Siglec-9 to decrease its immunogenicity by preventing macrophage phagocytosis.
He X, Zhang X, Wu B, Deng J, Zhang Y, Zhu A, Yuan Y, Lin Y, Chen A, Feng J, Wang X, Wu S, Liu Y, Liu J, Wang Y, Li R, Liang C, Yuan Q, Liang Y, Fang Q, Xi Z, Li W, Liang L, Zhang Z, Tang H, Peng Y, Ke C, Ma X, Cai W, Pan T, Liu B, Deng K, Chen J, Zhao J, Wei X, Chen R, Zhang Y, Zhang H. He X, et al. Nat Immunol. 2024 Apr;25(4):622-632. doi: 10.1038/s41590-024-01776-2. Epub 2024 Mar 7. Nat Immunol. 2024. PMID: 38454157
ST3 beta-galactoside alpha-2,3-sialyltransferase 1 (ST3Gal1) synthesis of Siglec ligands mediates anti-tumour immunity in prostate cancer.
Garnham R, Geh D, Nelson R, Ramon-Gil E, Wilson L, Schmidt EN, Walker L, Adamson B, Buskin A, Hepburn AC, Hodgson K, Kendall H, Frame FM, Maitland N, Coffey K, Strand DW, Robson CN, Elliott DJ, Heer R, Macauley M, Munkley J, Gaughan L, Leslie J, Scott E. Garnham R, et al. Commun Biol. 2024 Mar 6;7(1):276. doi: 10.1038/s42003-024-05924-0. Commun Biol. 2024. PMID: 38448753 Free PMC article.
Dissecting the Ability of Siglecs To Antagonize Fcγ Receptors.
McCord KA, Wang C, Anhalt M, Poon WW, Gavin AL, Wu P, Macauley MS. McCord KA, et al. ACS Cent Sci. 2024 Jan 17;10(2):315-330. doi: 10.1021/acscentsci.3c00969. eCollection 2024 Feb 28. ACS Cent Sci. 2024. PMID: 38435516 Free PMC article.
463 results